For the past half-century, psychiatric drug development has largely focused on tweaking neurotransmitter receptors and chemical pathways. Yet despite billions of dollars invested and major advances in neuroscience, truly innovative treatments for mental illness remain scarce. Disorders like depression, schizophrenia, and post-traumatic stress disorder (PTSD) continue to be managed with drugs discovered decades ago that often provide only partial relief, with remission rates of approximately 30-40% for treatment-resistant depression and 60-70% of schizophrenia patients experiencing persistent symptoms despite medication. This stagnation has prompted a paradigm shift - what if the key to treating mental illness is not just which receptor a drug targets, but how it changes the brain's processing of sensory information? In this treatise, I propose that many psychiatric conditions stem from breakdowns in the brain's sensory filtering mechanisms, the neural 'noise-cancelling' circuits that help us tune out irrelevant stimuli, and that effective therapies must restore these filtering functions. The cerebellum emerges as a critical hub for gating sensory input and maintaining mental stability, with recent evidence demonstrating state-dependent disruption of cerebellar-cortical connectivity during symptom provocation in PTSD. Intriguingly, psychedelic drugs may act as 'reset' buttons for these neural filters, reopening windows of plasticity to recalibrate how the brain perceives the world. This framework generates testable predictions, suggests novel therapeutic targets.
Craig Ferris (Tue,) studied this question.